drugset / Trial / NCT06844708

CMTS0929 for Inflammatory Bowel Disease

NCT06844708 ↗

Phase 0 Not yet recruiting 12 enrolled The Second Hospital of Nanjing Medical University
NaSingle-groupOpen-labelTreatment

Summary

This is a prospective, open-label, single-arm study to explore the safety and the efficacy of China Microbiota Transplantation System 0929 (CMTS0929) for patients with inflammatory bowel disease (IBD).

Timeline

Start
2025-02-20
Primary completion
2030-01-31
Completion
2030-07-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject CMTS0929 Other / unclassified — Other